WMU Biosciences Research & Commercialization Center (BRCC) is based at West Michigan University and established in 2003 with a special $10 million appropriation from the Michigan Legislature as a nonprofit investor, designed to provide seed funding to early-stage companies focused on the life science sector. BRCC considers a wide range of life science technologies across all indications including but not limited to: biotech therapeutics, diagnostics, medical devices, software, food, environmental and analytical services. BRCC also provides growth capital funding to Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) already servicing and on the market. The economic development focus of the BRCC aims to promote the growth of Michigan’s life sciences business sector and collaborates with the state’s entrepreneurial resource service providers.